LocationLocation:
Sutton
PositionPosition:
Myeloma Molecular Therapy
Salary Details:Salary Details:
£31,445 - £33,100 per annum
Contract:Contract:
Fixed term
External Advertising End DateAdvertising End Date:
25 Jun 2026

Key Information

Salary: Commencement on the salary range is subject to comparable skills and experience. 
Reporting to: Martin Kaiser
Duration of ContractFixed Term for 24 months
Hours per week: 35 hours per week (Full Time)
Location: Sutton
Closing Date: 25th of June 2026
 
We reserve the right to close the advert early should we receive a high volume of suitable applications. Early applications are encouraged for this reason.

Job Details

Under the guidance of Professor Martin Kaiser, we are seeking to recruit a Scientific Officer to contribute to The Haemato-Oncology Research Unit which is involved in a number of ground-breaking phase I, II and III clinical trials in myeloma and leukaemia, as well as being the central laboratory for scientific studies linked to a number of national clinical studies (including MRC, CRUK, and Myeloma UK funded studies).
 
The successful candidate will play a key role in processing, purification and bio- banking of clinical samples both from national trials as well as from the Royal Marsden Hospital. The post holder will apply molecular biology techniques that are established in our laboratory for the detection of genetic aberrations in patient samples.
 

About you

The successful candidate must have:

 A BSc in biological subject and ideally have experience of working to good laboratory practice & standard safety rules. Basic knowledge of computers that includes databases and word-processing is essential as well as experience with molecular biology techniques.

Experience with massively parallel sequencing, flow cytometry or primary cell culture would be an advantage. Knowledge of a diagnostic laboratory would also be advantageous.

Department/Directorate Information

The Division of Genetics and Epidemiology is internationally renowned for its pioneering work in understanding the underlying genetic causes of cancer risk. High-quality laboratory, epidemiological and clinical research within the division is driven by energetic, innovative leadership and complemented by participation in national and international research consortiums, clinical collaborations and technological partnerships. 

Professor Martin Kaiser's Myeloma Molecular Therapy Group's research aim is to design gentler, tailored therapies for patients with multiple myeloma.
 

What we offer

  • A dynamic and supportive research environment
  • Access to state-of-the-art facilities and professional development opportunities
  • Collaboration with leading researchers in the field
  • Competitive salary and pension

We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Martin Kaiser via Email on [email protected]


About The Institute of Cancer Research

Why work for us?

As a member of staff, you'll have exclusive access to a range of staff benefits.

The ICR is committed to supporting overseas applicants applying for roles, please click here to find out further information.

The Institute of Cancer Research, London, is one of the world's most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. Further information about working at the ICR can be found here.

At the Institute of Cancer Research, we champion diversity as we believe it fuels innovation and drives impactful research. We welcome applicants from all walks of life, valuing diverse perspectives that enrich our work.

Don't let a checklist of qualifications hold you back – if you're passionate about the role, we want to hear from you. Your unique experiences and backgrounds contribute to the richness of our team. We are committed to being an equal opportunity for all, regardless of ethnicity, gender, age, sexual orientation, disability, or any other dimension of diversity. Join us in creating an inclusive environment where everyone's voice is heard and valued.

Other jobs like this

Location
Sutton
Position
Myeloma Molecular Therapy
Salary Details:
£31,445 - £33,100 per annum
Contract:
Fixed term
External Advertising End Date
25 Jun 2026
Location
Sutton
Position
Adult Drug Development Unit
Contract:
Fixed term
External Advertising End Date
04 Jun 2026
Location
Chelsea
Position
Epigenetics and Cancer
Salary Details:
Salary range starting from £45,600 per annum
Contract:
Fixed term
External Advertising End Date
07 Jun 2026